Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

NCT00921310 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Withdrawal of funding from sponsor

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Pemetrexed
DRUG: Temsirolimus

Sponsor

Washington University School of Medicine